Global Reverse Transcriptase Sales Market Report 2023

Publication ID:

PB501233585

Publication Date:

January 3, 2023

Pages:

126

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
Market Analysis and Insights: Global Reverse Transcriptase Market
Due to the COVID-19 pandemic, the global Reverse Transcriptase market size is estimated to be worth US$ 321.7 million in 2022 and is forecast to a readjusted size of US$ 419 million by 2029 with a CAGR of 3.8% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, MMLV Reverse Transcriptase accounting for % of the Reverse Transcriptase global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While PCR segment is altered to an % CAGR throughout this forecast period.
Thermo Fisher, Promega, Roche, Bio-Rad and Takara Bio are the main producers of Reverse Transcriptase, the top 3 hold nearly 40% of the whole market. North America is the main market, which holds about 40% of the global marketshare.
Global Reverse Transcriptase Scope and Market Size
The global Reverse Transcriptase market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Reverse Transcriptase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
MMLV Reverse Transcriptase
AMV Reverse Transcriptase
Segment by Application
PCR
Sequencing
Cloning
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Reverse Transcriptase Market Overview
1.1 Reverse Transcriptase Product Scope
1.2 Reverse Transcriptase Segment by Type
1.2.1 Global Reverse Transcriptase Sales by Type (2018 & 2022 & 2029)
1.2.2 MMLV Reverse Transcriptase
1.2.3 AMV Reverse Transcriptase
1.3 Reverse Transcriptase Segment by Application
1.3.1 Global Reverse Transcriptase Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 PCR
1.3.3 Sequencing
1.3.4 Cloning
1.4 Reverse Transcriptase Market Estimates and Forecasts (2018-2029)
1.4.1 Global Reverse Transcriptase Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Reverse Transcriptase Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Reverse Transcriptase Price Trends (2018-2029)
2 Reverse Transcriptase Estimates and Forecasts by Region
2.1 Global Reverse Transcriptase Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Reverse Transcriptase Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Reverse Transcriptase Sales Market Share by Region (2018-2023)
2.2.2 Global Reverse Transcriptase Revenue Market Share by Region (2018-2023)
2.3 Global Reverse Transcriptase Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Reverse Transcriptase Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Reverse Transcriptase Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Reverse Transcriptase Estimates and Projections (2018-2029)
2.4.2 Europe Reverse Transcriptase Estimates and Projections (2018-2029)
2.4.3 China Reverse Transcriptase Estimates and Projections (2018-2029)
2.4.4 Japan Reverse Transcriptase Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Reverse Transcriptase Estimates and Projections (2018-2029)
2.4.6 India Reverse Transcriptase Estimates and Projections (2018-2029)
3 Global Reverse Transcriptase Competition Landscape by Players
3.1 Global Top Reverse Transcriptase Players by Sales (2018-2023)
3.2 Global Top Reverse Transcriptase Players by Revenue (2018-2023)
3.3 Global Reverse Transcriptase Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Reverse Transcriptase as of 2022)
3.4 Global Reverse Transcriptase Average Price by Company (2018-2023)
3.5 Manufacturers Reverse Transcriptase Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Reverse Transcriptase Market Size by Type
4.1 Global Reverse Transcriptase Historic Market Review by Type (2018-2023)
4.1.1 Global Reverse Transcriptase Sales by Type (2018-2023)
4.1.2 Global Reverse Transcriptase Revenue by Type (2018-2023)
4.1.3 Global Reverse Transcriptase Price by Type (2018-2023)
4.2 Global Reverse Transcriptase Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Reverse Transcriptase Sales Forecast by Type (2024-2029)
4.2.2 Global Reverse Transcriptase Revenue Forecast by Type (2024-2029)
4.2.3 Global Reverse Transcriptase Price Forecast by Type (2024-2029)
5 Global Reverse Transcriptase Market Size by Application
5.1 Global Reverse Transcriptase Historic Market Review by Application (2018-2023)
5.1.1 Global Reverse Transcriptase Sales by Application (2018-2023)
5.1.2 Global Reverse Transcriptase Revenue by Application (2018-2023)
5.1.3 Global Reverse Transcriptase Price by Application (2018-2023)
5.2 Global Reverse Transcriptase Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Reverse Transcriptase Sales Forecast by Application (2024-2029)
5.2.2 Global Reverse Transcriptase Revenue Forecast by Application (2024-2029)
5.2.3 Global Reverse Transcriptase Price Forecast by Application (2024-2029)
6 United States Reverse Transcriptase Market Facts & Figures
6.1 United States Reverse Transcriptase Sales by Company
6.1.1 United States Reverse Transcriptase Sales by Company (2018-2023)
6.1.2 United States Reverse Transcriptase Revenue by Company (2018-2023)
6.2 United States Reverse Transcriptase Sales Breakdown by Type
6.2.1 United States Reverse Transcriptase Sales Breakdown by Type (2018-2023)
6.2.2 United States Reverse Transcriptase Sales Breakdown by Type (2024-2029)
6.3 United States Reverse Transcriptase Sales Breakdown by Application
6.3.1 United States Reverse Transcriptase Sales Breakdown by Application (2018-2023)
6.3.2 United States Reverse Transcriptase Sales Breakdown by Application (2024-2029)
7 Europe Reverse Transcriptase Market Facts & Figures
7.1 Europe Reverse Transcriptase Sales by Company
7.1.1 Europe Reverse Transcriptase Sales by Company (2018-2023)
7.1.2 Europe Reverse Transcriptase Revenue by Company (2018-2023)
7.2 Europe Reverse Transcriptase Sales Breakdown by Type
7.2.1 Europe Reverse Transcriptase Sales Breakdown by Type (2018-2023)
7.2.2 Europe Reverse Transcriptase Sales Breakdown by Type (2024-2029)
7.3 Europe Reverse Transcriptase Sales Breakdown by Application
7.3.1 Europe Reverse Transcriptase Sales Breakdown by Application (2018-2023)
7.3.2 Europe Reverse Transcriptase Sales Breakdown by Application (2024-2029)
8 China Reverse Transcriptase Market Facts & Figures
8.1 China Reverse Transcriptase Sales by Company
8.1.1 China Reverse Transcriptase Sales by Company (2018-2023)
8.1.2 China Reverse Transcriptase Revenue by Company (2018-2023)
8.2 China Reverse Transcriptase Sales Breakdown by Type
8.2.1 China Reverse Transcriptase Sales Breakdown by Type (2018-2023)
8.2.2 China Reverse Transcriptase Sales Breakdown by Type (2024-2029)
8.3 China Reverse Transcriptase Sales Breakdown by Application
8.3.1 China Reverse Transcriptase Sales Breakdown by Application (2018-2023)
8.3.2 China Reverse Transcriptase Sales Breakdown by Application (2024-2029)
9 Japan Reverse Transcriptase Market Facts & Figures
9.1 Japan Reverse Transcriptase Sales by Company
9.1.1 Japan Reverse Transcriptase Sales by Company (2018-2023)
9.1.2 Japan Reverse Transcriptase Revenue by Company (2018-2023)
9.2 Japan Reverse Transcriptase Sales Breakdown by Type
9.2.1 Japan Reverse Transcriptase Sales Breakdown by Type (2018-2023)
9.2.2 Japan Reverse Transcriptase Sales Breakdown by Type (2024-2029)
9.3 Japan Reverse Transcriptase Sales Breakdown by Application
9.3.1 Japan Reverse Transcriptase Sales Breakdown by Application (2018-2023)
9.3.2 Japan Reverse Transcriptase Sales Breakdown by Application (2024-2029)
10 Southeast Asia Reverse Transcriptase Market Facts & Figures
10.1 Southeast Asia Reverse Transcriptase Sales by Company
10.1.1 Southeast Asia Reverse Transcriptase Sales by Company (2018-2023)
10.1.2 Southeast Asia Reverse Transcriptase Revenue by Company (2018-2023)
10.2 Southeast Asia Reverse Transcriptase Sales Breakdown by Type
10.2.1 Southeast Asia Reverse Transcriptase Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Reverse Transcriptase Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Reverse Transcriptase Sales Breakdown by Application
10.3.1 Southeast Asia Reverse Transcriptase Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Reverse Transcriptase Sales Breakdown by Application (2024-2029)
11 India Reverse Transcriptase Market Facts & Figures
11.1 India Reverse Transcriptase Sales by Company
11.1.1 India Reverse Transcriptase Sales by Company (2018-2023)
11.1.2 India Reverse Transcriptase Revenue by Company (2018-2023)
11.2 India Reverse Transcriptase Sales Breakdown by Type
11.2.1 India Reverse Transcriptase Sales Breakdown by Type (2018-2023)
11.2.2 India Reverse Transcriptase Sales Breakdown by Type (2024-2029)
11.3 India Reverse Transcriptase Sales Breakdown by Application
11.3.1 India Reverse Transcriptase Sales Breakdown by Application (2018-2023)
11.3.2 India Reverse Transcriptase Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Reverse Transcriptase Business
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Thermo Fisher Reverse Transcriptase Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 Promega
12.2.1 Promega Corporation Information
12.2.2 Promega Business Overview
12.2.3 Promega Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Promega Reverse Transcriptase Products Offered
12.2.5 Promega Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Business Overview
12.3.3 Roche Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Roche Reverse Transcriptase Products Offered
12.3.5 Roche Recent Development
12.4 Bio-Rad
12.4.1 Bio-Rad Corporation Information
12.4.2 Bio-Rad Business Overview
12.4.3 Bio-Rad Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Bio-Rad Reverse Transcriptase Products Offered
12.4.5 Bio-Rad Recent Development
12.5 Takara Bio
12.5.1 Takara Bio Corporation Information
12.5.2 Takara Bio Business Overview
12.5.3 Takara Bio Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Takara Bio Reverse Transcriptase Products Offered
12.5.5 Takara Bio Recent Development
12.6 Agilent
12.6.1 Agilent Corporation Information
12.6.2 Agilent Business Overview
12.6.3 Agilent Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Agilent Reverse Transcriptase Products Offered
12.6.5 Agilent Recent Development
12.7 Qiagen
12.7.1 Qiagen Corporation Information
12.7.2 Qiagen Business Overview
12.7.3 Qiagen Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Qiagen Reverse Transcriptase Products Offered
12.7.5 Qiagen Recent Development
12.8 Fapon Biotech
12.8.1 Fapon Biotech Corporation Information
12.8.2 Fapon Biotech Business Overview
12.8.3 Fapon Biotech Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Fapon Biotech Reverse Transcriptase Products Offered
12.8.5 Fapon Biotech Recent Development
12.9 Toyobo
12.9.1 Toyobo Corporation Information
12.9.2 Toyobo Business Overview
12.9.3 Toyobo Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Toyobo Reverse Transcriptase Products Offered
12.9.5 Toyobo Recent Development
12.10 Vazyme
12.10.1 Vazyme Corporation Information
12.10.2 Vazyme Business Overview
12.10.3 Vazyme Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Vazyme Reverse Transcriptase Products Offered
12.10.5 Vazyme Recent Development
12.11 New England Biolabs
12.11.1 New England Biolabs Corporation Information
12.11.2 New England Biolabs Business Overview
12.11.3 New England Biolabs Reverse Transcriptase Sales, Revenue and Gross Margin (2018-2023)
12.11.4 New England Biolabs Reverse Transcriptase Products Offered
12.11.5 New England Biolabs Recent Development
13 Reverse Transcriptase Manufacturing Cost Analysis
13.1 Reverse Transcriptase Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Reverse Transcriptase
13.4 Reverse Transcriptase Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Reverse Transcriptase Distributors List
14.3 Reverse Transcriptase Customers
15 Market Dynamics
15.1 Reverse Transcriptase Industry Trends
15.2 Reverse Transcriptase Market Drivers
15.3 Reverse Transcriptase Market Challenges
15.4 Reverse Transcriptase Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

Companies Mentioned:

Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂